This brand name is authorized in France, Tunisia
The drug AFTAGEL contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Lidocaine
UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE
|
|
Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. |
|
2
Zinc sulfate
UNII 89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM
|
|
Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N01BB52 | Lidocaine, combinations | N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 60007960 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 7623081 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
